Kateryna Kuzmychova
Psychiatric/Mental Health · Everett, WANPI 1447819172
Payments from drug & device makers
Across 124 payments — averaging $25.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$686
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$525
- AbbVie$482
- Axsome Therapeutics, Inc.$313
- Teva Pharmaceuticals USA, Inc.$257
- Johnson & Johnson$170
- plus $786 from 12 others
What the payments were for
- Consulting fees$1154%
- Food & beverage$3,02894%
- Education$772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 21 | $686 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $525 |
| AbbVie(2 entities) | 28 | $482 |
| Axsome Therapeutics, Inc. | 6 | $313 |
| Teva Pharmaceuticals USA, Inc. | 12 | $257 |
| Johnson & Johnson | 5 | $170 |
| Neurocrine Biosciences, Inc. | 2 | $124 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $107 |
| Lundbeck LLC | 3 | $93 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Bausch Health US, LLC | 3 | $63 |
| E.r. Squibb & Sons, L.L.C. | 3 | $56 |
| Sunovion Pharmaceuticals Inc. | 5 | $54 |
| Corium, LLC | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Tris Pharma Inc | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,220 in reported general payments places this provider in the 90th percentile of 931 psychiatric/mental health providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 40 | $1,869 |
| Memantine Hcl | 11 | $1,433 |
| Vilazodone Hcl | 13 | $1,328 |
| Clozapine | 11 | $1,142 |
| Clonazepam | 86 | $1,055 |
| Mirtazapine | 45 | $903 |
| Lurasidone Hcl | 12 | $675 |
| Buspirone Hcl | 36 | $663 |
| Escitalopram Oxalate | 51 | $643 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 11 | $610 |
| Gabapentin | 30 | $581 |
| Bupropion XlBupropion Hcl | 23 | $565 |
| Quetiapine Fumarate | 32 | $469 |
| Lamotrigine | 31 | $415 |
| Lorazepam | 37 | $345 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Everett
- Angela KokinakosEverett$9K
- Hyesoon ChoiEverett$8K
- Sandra CarrierEverett$7K
- Jana RobisonEverett$5K
- Laura PerezEverett$5K
- Isabel Zaragoza-SanchezEverett$4K
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Dawn MasonSpokane$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.